Hefang Xiao1, Yonghui Dong2, Likang Xiao2, Xiaming Liang2, Jia Zheng1. 1. Department of Orthopedics, Henan Provincial People's Hospital, People's Hospital of Zhengzhou University, School of Clinical Medicine, Zhengzhou University No. 7 Weiwu Road, Jinshui District, Zhengzhou, Henan, China. 2. Department of Orthopedics, Henan Provincial People's Hospital Zhengzhou, Henan, China.
Abstract
BACKGROUND: A deeper understanding of new prognostic and diagnostic biomarkers for vitiligo, an autoimmune disease, is needed. The purpose of this study is to identify the underlying long noncoding RNAs (lncRNAs) and immune infiltration related to the cause of vitiligo. METHODS: The microarray data (GSE75819) were available to be downloaded from NCBI-GEO. Eight hub genes were identified from the Protein-protein interaction (PPI) network by the dissection of differentially expressed genes (DEG), Kyoto Gene and Genomic Encyclopedia (KEGG) expansion pathway, and Gene Ontology (GO). Further analysis based on the immune infiltration as well as the correlation between DEGs and immune cells was performed. Our conclusions were verified by using the GSE534 eventually. RESULTS: According to our analysis, we obtained a total of 666 DEGs and 8 hub genes that include ECT2, CCT8, VRK1, UQCRH, EBNA1BP2, CRY2, IFIH1, and BCCIP, which may play an important role in vitiligo. Moreover, the immune infiltration profiles varied significantly between normal and vitiligo tissues. Compared with normal tissues, vitiligo tissues contained a greater proportion of mast cells (P<0.05). The analysis revealed that T cells regulatory (Tregs) have a negative correlation with the VRK1 expression (R=-0:77, P<0.001), whereas the mast cells resting have a positive correlation with the VRK1 expression (R=0:72, P<0.001) in vitiligo. CONCLUSION: The gene expression profile of vitiligo was realized by a bioinformatics method. The expressions of 8 hub genes and 22 immune cells were found, as the same as CRY2 and VRK1 have a special correlation with immune cells, which may be a significant cause of the pathogenesis of vitiligo. This provides a new idea for the diagnosis and treatment of vitiligo. IJCEP
BACKGROUND: A deeper understanding of new prognostic and diagnostic biomarkers for vitiligo, an autoimmune disease, is needed. The purpose of this study is to identify the underlying long noncoding RNAs (lncRNAs) and immune infiltration related to the cause of vitiligo. METHODS: The microarray data (GSE75819) were available to be downloaded from NCBI-GEO. Eight hub genes were identified from the Protein-protein interaction (PPI) network by the dissection of differentially expressed genes (DEG), Kyoto Gene and Genomic Encyclopedia (KEGG) expansion pathway, and Gene Ontology (GO). Further analysis based on the immune infiltration as well as the correlation between DEGs and immune cells was performed. Our conclusions were verified by using the GSE534 eventually. RESULTS: According to our analysis, we obtained a total of 666 DEGs and 8 hub genes that include ECT2, CCT8, VRK1, UQCRH, EBNA1BP2, CRY2, IFIH1, and BCCIP, which may play an important role in vitiligo. Moreover, the immune infiltration profiles varied significantly between normal and vitiligo tissues. Compared with normal tissues, vitiligo tissues contained a greater proportion of mast cells (P<0.05). The analysis revealed that T cells regulatory (Tregs) have a negative correlation with the VRK1 expression (R=-0:77, P<0.001), whereas the mast cells resting have a positive correlation with the VRK1 expression (R=0:72, P<0.001) in vitiligo. CONCLUSION: The gene expression profile of vitiligo was realized by a bioinformatics method. The expressions of 8 hub genes and 22 immune cells were found, as the same as CRY2 and VRK1 have a special correlation with immune cells, which may be a significant cause of the pathogenesis of vitiligo. This provides a new idea for the diagnosis and treatment of vitiligo. IJCEP
Authors: Paul Shannon; Andrew Markiel; Owen Ozier; Nitin S Baliga; Jonathan T Wang; Daniel Ramage; Nada Amin; Benno Schwikowski; Trey Ideker Journal: Genome Res Date: 2003-11 Impact factor: 9.043
Authors: Inmaculada López-Sánchez; Alberto Valbuena; Marta Vázquez-Cedeira; Jyoti Khadake; Marta Sanz-García; Alejandro Carrillo-Jiménez; Pedro A Lazo Journal: FEBS Lett Date: 2014-01-31 Impact factor: 4.124
Authors: Matthew E Ritchie; Belinda Phipson; Di Wu; Yifang Hu; Charity W Law; Wei Shi; Gordon K Smyth Journal: Nucleic Acids Res Date: 2015-01-20 Impact factor: 16.971
Authors: Ana I Esquifino; Pilar Cano; Vanesa Jiménez-Ortega; Pilar Fernández-Mateos; Daniel P Cardinali Journal: Endocrine Date: 2007-09-29 Impact factor: 3.633
Authors: F Sassi; S Cazzaniga; G Tessari; L Chatenoud; A Reseghetti; L Marchesi; G Girolomoni; L Naldi Journal: Br J Dermatol Date: 2008-08-19 Impact factor: 9.302
Authors: Damian Szklarczyk; John H Morris; Helen Cook; Michael Kuhn; Stefan Wyder; Milan Simonovic; Alberto Santos; Nadezhda T Doncheva; Alexander Roth; Peer Bork; Lars J Jensen; Christian von Mering Journal: Nucleic Acids Res Date: 2016-10-18 Impact factor: 16.971
Authors: Ying Jin; Stanca A Birlea; Pamela R Fain; Tracey M Ferrara; Songtao Ben; Sheri L Riccardi; Joanne B Cole; Katherine Gowan; Paulene J Holland; Dorothy C Bennett; Rosalie M Luiten; Albert Wolkerstorfer; J P Wietze van der Veen; Anke Hartmann; Saskia Eichner; Gerold Schuler; Nanja van Geel; Jo Lambert; E Helen Kemp; David J Gawkrodger; Anthony P Weetman; Alain Taïeb; Thomas Jouary; Khaled Ezzedine; Margaret R Wallace; Wayne T McCormack; Mauro Picardo; Giovanni Leone; Andreas Overbeck; Nanette B Silverberg; Richard A Spritz Journal: Nat Genet Date: 2012-05-06 Impact factor: 38.330